Effect of Neurodynamic Mobilization of Vagus Nerve on Irritable Bowel Syndrome in Women
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 45 years old?
Source: NCT07560345, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cairo University
- Trial code
- NCT07560345
- Record updated
- 7 May 2026
- Original description
goal of this interventional study to investigate the effect of neurodynamic mobilization of vagus nerve on irritable bowel syndrome in women. The main question it aims to answer is: is there an effect of neurodynamic mobilization of the vagus nerve on irritable bowel syndrome? The intervention will include neurodynamic mobilization of vagus nerve sessions ,Participants will receive the treatment for 6 week. Assessment will be done before and after treatment.Read full original descriptionShow less
goal of this interventional study to investigate the effect of neurodynamic mobilization of vagus nerve on irritable bowel syndrome in women. The main question it aims to answer is: is there an effect of neurodynamic mobilization of the vagus nerve on irritable bowel syndrome? The intervention will include neurodynamic mobilization of vagus nerve sessions ,Participants will receive the treatment for 6 week. Assessment will be done before and after treatment.
Inclusion: 32 Females with mild to moderate IBS ,were recruited for this study by referral from a physician; aged 20-45 (i.e., the most common age for developing IBS); Patients must experience abdominal pain recurring at least once weekly over the past three months; This pain must be linked to two or more of the following features: occurring in relation to defecation, accompanied by a change in stool frequency, or accompanied by a change in stool form or appearance; Symptoms should have been present during the last three months, with onset at least six months before diagnosis.
Exclusion: Organic gastrointestinal disorders; Coexisting cardiovascular, respiratory, renal, or hepatic conditions; Blood disorders. (e.g., hemophilia, coagulation disorders, leukemia, thalassemia, sickle cell disease); Neurological or musculoskeletal conditions affecting muscle tone; Psychiatric illnesses ( patients with depression in the absence of IBS); A history of gastrointestinal surgery or resection, , or other chronic diseases associated with gastrointestinal issues such as inflammatory bowel disease, ulcers, or cancer; A history of alcohol or drug abuse, abdominal surgery within the past six months; Recent cervical or cardiac surgery, or recent major trauma; Subjects will be excluded if they have:; Thyroid abnormalities; Pregnancy; Fibromyalgia.